AGER and neoplasm: It could be shown that this antibody against S100A7, named 6F5, blocks the S100A7/RAGE interaction, thereby inhibiting S100A7-induced MMP9 activity, leading to reduced tumor growth, cell migration and angiogenesis in a xenograft cancer model.